Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Ursodiol capsules, used to treat primary biliary cirrhosis, in America.
Fingolimod capsules is indicated for the treatment of patients with relapsing forms of multiple sclerosis. While, Verapamil Hydrochloride Injection, is used to rapidly/temporarily restore normal heartbeats in people with certain heart rhythm disorders.
Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.
Drug firm Zydus Cadila on Friday said it has received final nod from the US health regulator to market its generic Doxorubicin Hydrochloride Liposome injection, used for treatment of certain types of cancer, in the American market.
Drug firm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium Besylate Injection, a muscle relaxant given before general anesthesia.
Drug firm Zydus Cadila on Wednesday said the phase I clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, has been completed and it will commence phase II clinical trials from August 6.
Drug firm Zydus Cadila is aiming to complete clinical trials of COVID-19 vaccine candidate ZyCoV-D within seven months, the company's chairman said today. On Wednesday, the company had started clinical trials of its COVID-19 vaccine candidate with the first human dosing.
Drug firm Zydus Cadila on Friday said it has received approval from Mexico's regulatory authority Cofepris to conduct clinical trials in the Latin American country with its biological therapy "Pegylated Interferon alpha-2b" for treatment of COVID-19.
The company said the Jarod facility in Gujarat is an important one for Zydus' US injectable portfolio as five abbreviated new drug application (ANDAs) have been approved from this facility and another six have been filed, awaiting approval.
Drug firm Zydus Cadila on Wednesday announced that it has started human clinical trials of its coronavirus vaccine candidate ZyCoV-D. In the phase of trials, the company will be enrolling over 1,000 subjects across multiple clinical study sites in India, it said in a regulatory filing.
Drug firm Zydus Cadila on Friday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19.
Drug firm Zydus Cadila on Friday said it has launched generic Enzalutamide capsules used for the treatment of prostate cancer which costs nearly 70 per cent less than the currently available similar products in India.
Pharmaceutical major Zydus Cadila on Saturday said it has initiated an accelerated research programme with multiple teams in India and Europe for developing a vaccine for coronavirus.
New Delhi: Zydus Cadila has recalled 10,200 bottles of an allergy-relief drug in the United States after another drug for high blood pressure was found in one of the bottles, the U.S. Food and Drug
Top News
Latest News
